Dr. Grace G. Shumaker, MD

Dr. Shumaker practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Dr. Shumaker's NPI, 1912901513, was assigned on June 10, 2005. Dr. Shumaker graduated from University of Mississippi School of Medicine in 1991. Dr. Shumaker holds Mississippi license 11423.

Dr. Shumaker's primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Dr. Shumaker's primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. Dr. Shumaker is also affiliated with FMOL Health | St. Dominic. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Dr. Shumaker to 2 more hospitals and 1 behavioral health center, each named with a free account. Dr. Shumaker's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shumaker practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Shumaker's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Shumaker is licensed in Mississippi.

CMS data shows 572 Medicare services from Dr. Shumaker across 7 procedure codes in 2024, for 213 Medicare patients. Medicare paid $35,183 for them.

CMS counts 213 Medicare patients who saw Dr. Shumaker in 2024. The largest group is 65 to 74, with 97 patients. 75% of them have high blood pressure, and 57% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.41, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shumaker's median patient age at 62, with 65% women.

In 2024, Dr. Shumaker wrote 866 Medicare Part D claims for 141 patients. 84% of them were for generic drugs. CMS names the drug for 660 of them, across 23 drugs with 11 or more claims each, at $449,927 in total drug cost. In 2023, CMS named 561 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Shumaker for performance year 2024, reported as part of a group. Dr. Shumaker accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Shumaker in 2014. Dr. Shumaker's most frequent co-authors are Helen Kent Chew, MD, James Patrick Daugherty, MD and Lee S. Schwartzberg, MD.

Dmand AI links Dr. Shumaker to 2 clinical trials, 2 of them phase 3 studies. Conditions studied include Breast Neoplasms, Multiple Endocrine Neoplasia Type 1 and Breast Diseases. Novartis Pharmaceuticals sponsors the most, 2.

CMS Open Payments shows 406 general payments to Dr. Shumaker from 72 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Celgene Corporation paid the most, $516.

Dr. Shumaker graduated from University of Mississippi School of Medicine in 1991.